Healthy volunteers 247031 Part C
Study Dates: TBD - TBD
Trial Number
247031
Group
● Healthy Volunteer
● Non-Childbearing Females
Compensation
Up to: $4,017
Gender
Male, Female
Age
18-55
Additional Information
For
the Treatment Period, you will be admitted to the Unit on Day ‑1 (the day
before the first dosing) or Day -2 (if you are participating in a cohort
that involves CSF sampling). You will then be required to stay in
the Unit for 18 days and 17 nights or, if you are participating in a
cohort with CSF sampling, for 19 days and 18 nights. 1
screening visit, up-to 18 overnight stays (depending on cohort) and 1
follow-up phone call.
We will compensate you for your time and inconvenience (which includes travel expenses and compensation for any lifestyle restrictions) to the sum of £4017.50 (£4777.50 if you are participating in cohort with CSF sampling).
Details
The Study drug is being developed to treat patients who suffer from a disease known as Multiple System Atrophy (A fatal neuro-degenerative disorder where brain cells progressively die leading to loss of many body functions, including breathing and eating.